Post
Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride – statnews.com
- Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride statnews.com
- Lilly to buy Boston biotech Kelonia for $3.25 billion in latest Mass. investment The Boston Globe
- Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com
- Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo